What is Venetoclax/ABT-199?
Feb 10,2020

References
- Related articles
- Related Qustion
- Indications and adverse reactions of ABT-199 Jul 30, 2025
Venetoclax (ABT-199) is an important anti-cancer drug jointly developed by Swiss pharmaceutical company Roche and US biotechnology company AbbVie.
- BCL2 inhibitor ABT-199 Mar 25, 2025
ABT-199(venetoclax, RG7601, GDC-0199) is a new selective small molecule inhibitor of BCL-2 that appears to spare platelets while achieving potent antitumor activity.
- Mechanisms of resistance to ABT-199 in leukemia and lymphoma cell lines Apr 2, 2024
ABT-199 (Venetoclax) is a potent, orally bioavailable, selective inhibitor of BCL-2. It is approved for the treatment of first-line and relapsed/refractory chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML).
Isethionic Acid is an important anion which could be found in animals or persons. A lot of researchers have done some studies about isethionic acid.....
Jan 19,2020SaccharidesGanciclovir is a potent inhibitor of herpes viruses, including CMV. It is a nucleoside analogue that suppresses the replication of herpes viruses and functions as a virustatic agent.....
Feb 10,2020InhibitorsABT-199
1257044-40-8You may like
- ABT-199
-
- $10.00 / 1ASSAYS
- 2025-08-04
- CAS:1257044-40-8
- Min. Order: 1ASSAYS
- Purity: 99%
- Supply Ability: 10 ton
- ABT-199
-
- $0.00 / 1kg
- 2025-07-29
- CAS:1257044-40-8
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 10T
- ABT-199
-
- $0.00 / 25KG
- 2025-07-25
- CAS:1257044-40-8
- Min. Order: 1KG
- Purity: 98.0%
- Supply Ability: 10000KGS